Pregled bibliografske jedinice broj: 734100
Do we know all effects of heparins in hemodialyzed patients?
Do we know all effects of heparins in hemodialyzed patients? // Acta medica Croatica, 66(36) (2012), 215-220 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 734100 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Do we know all effects of heparins in hemodialyzed
patients?
Autori
Šain, Milenka ; Ljutić, Dragan ; Kovačić, Vedran ; Radić, Josipa ; Jeličić, Ivo
Izvornik
Acta medica Croatica (1330-0164) 66(36)
(2012);
215-220
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
heparins ; hemodialyzed patients
Sažetak
Anticoagulation with heparins during hemodialysis (HD) is aimed at preventing the activation of coagulation in the extracorporeal circuit. As HD patients are exposed to unfractionated and low molecular weight heparins (LMWH) for years, non- hemorrhagic effects (osteoporosis, reduction of elevated blood pressure, with lesser intra- and interdialytic hypotensive episodes, effects on brain microvascular circulation and decreasing vascular dementia and Alzheimer's disease, and chronic and malignant diseases) require new trials with individualized doses of heparins.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE